Compare NRC & TCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NRC | TCPC |
|---|---|---|
| Founded | 1981 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 428.2M | 444.6M |
| IPO Year | N/A | 2012 |
| Metric | NRC | TCPC |
|---|---|---|
| Price | $15.41 | $4.80 |
| Analyst Decision | | Sell |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.50 |
| AVG Volume (30 Days) | 98.6K | ★ 1.2M |
| Earning Date | 02-03-2026 | 02-27-2026 |
| Dividend Yield | 4.01% | ★ 23.05% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.50 | N/A |
| Revenue | $137,390,000.00 | ★ $219,119,058.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $31.88 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.76 | $4.85 |
| 52 Week High | $22.79 | $9.48 |
| Indicator | NRC | TCPC |
|---|---|---|
| Relative Strength Index (RSI) | 33.73 | 31.15 |
| Support Level | $14.93 | $4.91 |
| Resistance Level | $16.45 | $5.41 |
| Average True Range (ATR) | 1.46 | 0.16 |
| MACD | -0.77 | -0.06 |
| Stochastic Oscillator | 6.07 | 1.85 |
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.
BlackRock TCP Capital Corp is an externally-managed specialty finance company focused on middle-market lending. Its investment objective is to achieve high total returns through current income and capital appreciation, with an emphasis on principal protection. It seeks to achieve investment objective through investments in debt securities of middle-market companies. The group generates returns through a combination of the receipt of contractual interest payments on debt investments and origination and similar fees, and, to a lesser extent, equity appreciation through options, warrants, conversion rights or direct equity investments.